Trial Profile
A Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Alendronic acid For the Treatment of Osteoporosis in Postmenopausal Women.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms FIT
- 25 Nov 2015 New trial record